ESMO 2019: Targeted therapy slows progression of advanced prostate cancer
Targeting faulty DNA repair mechanisms in advanced castration resistant prostate cancer can slow progression and…
Targeting faulty DNA repair mechanisms in advanced castration resistant prostate cancer can slow progression and…